ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,624, issued on Aug. 18, was assigned to Amplia Therapeutics Ltd. (Melbourne, Australia).
"Methods of treating pulmonary fibrosis" was invented by Chris Burns (Melbourne, Australia), John Lambert (Melburne, Australia) and Mark Graeme Devlin (Melbourne, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating or preventing pulmonary fibrosis in a patient in need thereof by administering a FAK inhibitor defined by formula I or a pharmaceutically acceptable derivative thereof to said patient: (I)"
The patent was filed on May 17, 2021, under Application No. 17/926,114.
*For further information, including images, charts and tables, ...